View Clinical Trial (Medical Research Study)

A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax - NCT00886613-22003(Clinical Trial 288393)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Annandale
State:  
VA
Zip Code: 22003
Conditions: Herpes Zoster
Purpose: A study in two parts to evaluate the responsiveness of various biomarkers of immunity to Varicella-Zoster Virus following repeated immunizations with heat treated VZV vaccine V212 or with Zostavax.
Study summary:
Criteria: Inclusion Criteria: - Subject has prior history of Varicella - Female subjects are of non-childbearing potential Exclusion Criteria: - Subject has had a hypersensitivity reaction to any vaccine component - Subject has a prior history of Herpes Zoster - Subject has received any Varicella or Zoster vaccine including Zostavax - Subject has a history of immunosuppression caused by disease, corticosteroids, cancer therapy or organ transplant - Subject has an active cancer - Subject has received or will receive a live virus vaccine or an inactivated virus vaccine 4 weeks prior to participating in study (with the exception of influenza vaccine) - Subject is not bed-ridden or homebound
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 16, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.